Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R. 4016 - Department of Defense Appropriations Act, 2026 S. 2572 - Department of Defense Appropriations Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R.3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 H.R.7148 - Consolidated Appropriations Act, 2026 In January, joined with coalition partners to thank House leadership for including critical funding for programs that are essential to individuals with disabilities, chronic conditions, and injuries in the appropriations conference report. Supported the passage of H.R.7148, the Consolidated Appropriations Act, which included funding priorities for FY 26. Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program. Joined with coalition partners to send a letter to the Appropriations Committee leadership on NIH funding.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2026 · third_quarter · Q3
H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R.9495 - Department of Defense Appropriations Act, 2027 Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. In April joined with coalition partners on a Congressional letter requesting $90.47 Million for the NIEHS Superfund Program, including the SRP and WTP.These programs are housed in NIH. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program.
Source: Senate LDA
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act Continued to advocate on H.R.1 implementation. Submitted and joined coalition comments to CMS on the proposed rule on Interoperability Standards and Prior Authorization for Drugs. The aimed looked to modernize prior authorization processes and improve interoperability across the healthcare system. Joined with coalition partners to respond to a pair of proposed Local Coverage Determinations (LCDs) and the impacts how it would impact how power seat elevation systems are covered under Medicare. In May, Joined a coalition letter to Congress requesting outreach to CMS to encourage the agency to rescind the Low Vision Aid Exclusion under the Medicare regulations.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7779 - Healthy Brains Act of 2026 H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 Over the course of the last quarter joined with various coalition partners to advocate for NIH funding grants for medical research. Submitted comments to the National Institutes of Health on the agency's request for feedback on its Framework for the next NIH-Wide Strategic Plan.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7779 - Healthy Brains Act of 2026 H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 In July, the National MS Society submitted comments on the Office of Management and Budgets (OMB) proposed Regulation for Federal Financial Assistance, expressing concern over impacts the rule may have on grant review and federal research investments.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7148 - Consolidated Appropriations Act, 2026 H.R.7779 - Healthy Brains Act of 2026 Over the course of the last quarter joined with various coalition partners to advocate for NIH funding grants for medical research. Submitted comments to U.S. Department of Health and Human Services (HHS) on the agency's request for feedback on how current HHS regulations affect the adoption and use of artificial intelligence (AI) in clinical care.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act Continued to advocate on H.R.1 implementation. In July, the National MS Society commented on CMSs Medicaid Community Engagement Requirement centering around administrative barriers that could jeopardize health coverage for people living with MS and other chronic conditions, and urging CMS to maintain robust protections and exemptions to ensure uninterrupted access to care and treatment.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7148 - Consolidated Appropriations Act, 2026 Continued to advocate on H.R.1 implementation. Submitted and joined coalition comments to HHS on the proposed rule to revise the Medicare Advantage (MA), Medicare Prescription Drug Benefit (Part D), and Medicare cost plan regulations.
Accelerating Kids’ Access to Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Accelerating Kids’ Access to Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
Accelerating Kids’ Access to Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Credit for Caring Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Credit for Caring Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
Credit for Caring Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Insurance Fraud Accountability Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
Insurance Fraud Accountability Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Insurance Fraud Accountability Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Mobility Means Freedom Tax Credit Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Mobility Means Freedom Tax Credit Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
Mobility Means Freedom Tax Credit Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Lifespan Respite Care Reauthorization Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
Lifespan Respite Care Reauthorization Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Lifespan Respite Care Reauthorization Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Websites and Software Applications Accessibility Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Websites and Software Applications Accessibility Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Websites and Software Applications Accessibility Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
Improving Seniors’ Timely Access to Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Improving Seniors’ Timely Access to Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Improving Seniors’ Timely Access to Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
ENROLL Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
ENROLL Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
ENROLL Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R. 4016 - Department of Defense Appropriations Act, 2026 S. 2572 - Department of Defense Appropriations Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R.3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 H.R.7148 - Consolidated Appropriations Act, 2026 In January, joined with coalition partners to thank House leadership for including critical funding for programs that are essential to individuals with disabilities, chronic conditions, and injuries in the appropriations conference report. Supported the passage of H.R.7148, the Consolidated Appropriations Act, which included funding priorities for FY 26. Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program. Joined with coalition partners to send a letter to the Appropriations Committee leadership on NIH funding.
Department of Defense Appropriations Act, 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R. 4016 - Department of Defense Appropriations Act, 2026 S. 2572 - Department of Defense Appropriations Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R.3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 H.R.7148 - Consolidated Appropriations Act, 2026 In January, joined with coalition partners to thank House leadership for including critical funding for programs that are essential to individuals with disabilities, chronic conditions, and injuries in the appropriations conference report. Supported the passage of H.R.7148, the Consolidated Appropriations Act, which included funding priorities for FY 26. Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program. Joined with coalition partners to send a letter to the Appropriations Committee leadership on NIH funding.
PBM Reform Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
PBM Reform Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
PBM Reform Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Telehealth Modernization Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
Telehealth Modernization Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Telehealth Modernization Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R. 4016 - Department of Defense Appropriations Act, 2026 S. 2572 - Department of Defense Appropriations Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R.3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 H.R.7148 - Consolidated Appropriations Act, 2026 In January, joined with coalition partners to thank House leadership for including critical funding for programs that are essential to individuals with disabilities, chronic conditions, and injuries in the appropriations conference report. Supported the passage of H.R.7148, the Consolidated Appropriations Act, which included funding priorities for FY 26. Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program. Joined with coalition partners to send a letter to the Appropriations Committee leadership on NIH funding.
Seniors Deserve SMARTER Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Seniors Deserve SMARTER Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Seniors Deserve SMARTER Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Consolidated Appropriations Act, 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7148 - Consolidated Appropriations Act, 2026 H.R.7779 - Healthy Brains Act of 2026 Over the course of the last quarter joined with various coalition partners to advocate for NIH funding grants for medical research. Submitted comments to U.S. Department of Health and Human Services (HHS) on the agency's request for feedback on how current HHS regulations affect the adoption and use of artificial intelligence (AI) in clinical care.
Consolidated Appropriations Act, 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7148 - Consolidated Appropriations Act, 2026 Continued to advocate on H.R.1 implementation. Submitted and joined coalition comments to HHS on the proposed rule to revise the Medicare Advantage (MA), Medicare Prescription Drug Benefit (Part D), and Medicare cost plan regulations.
Consolidated Appropriations Act, 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R. 4016 - Department of Defense Appropriations Act, 2026 S. 2572 - Department of Defense Appropriations Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R.3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 H.R.7148 - Consolidated Appropriations Act, 2026 In January, joined with coalition partners to thank House leadership for including critical funding for programs that are essential to individuals with disabilities, chronic conditions, and injuries in the appropriations conference report. Supported the passage of H.R.7148, the Consolidated Appropriations Act, which included funding priorities for FY 26. Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program. Joined with coalition partners to send a letter to the Appropriations Committee leadership on NIH funding.
HEALTHY BRAINS Act of 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7148 - Consolidated Appropriations Act, 2026 H.R.7779 - Healthy Brains Act of 2026 Over the course of the last quarter joined with various coalition partners to advocate for NIH funding grants for medical research. Submitted comments to U.S. Department of Health and Human Services (HHS) on the agency's request for feedback on how current HHS regulations affect the adoption and use of artificial intelligence (AI) in clinical care.
HEALTHY BRAINS Act of 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7779 - Healthy Brains Act of 2026 H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 Over the course of the last quarter joined with various coalition partners to advocate for NIH funding grants for medical research. Submitted comments to the National Institutes of Health on the agency's request for feedback on its Framework for the next NIH-Wide Strategic Plan.
HEALTHY BRAINS Act of 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7779 - Healthy Brains Act of 2026 H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 In July, the National MS Society submitted comments on the Office of Management and Budgets (OMB) proposed Regulation for Federal Financial Assistance, expressing concern over impacts the rule may have on grant review and federal research investments.
Every Dollar Counts Act of 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
Every Dollar Counts Act of 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R.9495 - Department of Defense Appropriations Act, 2027 Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. In April joined with coalition partners on a Congressional letter requesting $90.47 Million for the NIEHS Superfund Program, including the SRP and WTP.These programs are housed in NIH. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program.
Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R.9495 - Department of Defense Appropriations Act, 2027 Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. In April joined with coalition partners on a Congressional letter requesting $90.47 Million for the NIEHS Superfund Program, including the SRP and WTP.These programs are housed in NIH. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program. In May, joined with coalition partners to thank SAC and HAC LHHS committees for including provisions aimed at safeguarding public health investments. Additionally joined with coalition partners on a letter to Defense committee leadership to increase funding for the Congressionally Directed Medical Research Programs (CDMRP) at the Department of Defense (DoD).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R.9495 - Department of Defense Appropriations Act, 2027 Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. In April joined with coalition partners on a Congressional letter requesting $90.47 Million for the NIEHS Superfund Program, including the SRP and WTP.These programs are housed in NIH. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program. In May, joined with coalition partners to thank SAC and HAC LHHS committees for including provisions aimed at safeguarding public health investments. Additionally joined with coalition partners on a letter to Defense committee leadership to increase funding for the Congressionally Directed Medical Research Programs (CDMRP) at the Department of Defense (DoD).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7779 - Healthy Brains Act of 2026 H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 Over the course of the last quarter joined with various coalition partners to advocate for NIH funding grants for medical research. Submitted comments to the National Institutes of Health on the agency's request for feedback on its Framework for the next NIH-Wide Strategic Plan.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R.9495 - Department of Defense Appropriations Act, 2027 Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. In April joined with coalition partners on a Congressional letter requesting $90.47 Million for the NIEHS Superfund Program, including the SRP and WTP.These programs are housed in NIH. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R.7779 - Healthy Brains Act of 2026 H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 In July, the National MS Society submitted comments on the Office of Management and Budgets (OMB) proposed Regulation for Federal Financial Assistance, expressing concern over impacts the rule may have on grant review and federal research investments.
Air Carrier Access Amendments Act of 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 9373: Air Carrier Access Amendments Act of 2026 S. 4829: Air Carrier Access Amendments Act In April joined with coalition partners a letter to the Department Of Transportation requesting updates on the status of DOTs implementation of the disability-related provisions of the FAA Reauthorization Act of 2024 and urging DOT to meet the requirements specified by Congress.
Department of Defense Appropriations Act, 2027
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R.9495 - Department of Defense Appropriations Act, 2027 Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. In April joined with coalition partners on a Congressional letter requesting $90.47 Million for the NIEHS Superfund Program, including the SRP and WTP.These programs are housed in NIH. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program. In May, joined with coalition partners to thank SAC and HAC LHHS committees for including provisions aimed at safeguarding public health investments. Additionally joined with coalition partners on a letter to Defense committee leadership to increase funding for the Congressionally Directed Medical Research Programs (CDMRP) at the Department of Defense (DoD).
Department of Defense Appropriations Act, 2027
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R.9495 - Department of Defense Appropriations Act, 2027 Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. In April joined with coalition partners on a Congressional letter requesting $90.47 Million for the NIEHS Superfund Program, including the SRP and WTP.These programs are housed in NIH. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program.
Improving Seniors’ Timely Access to Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Improving Seniors’ Timely Access to Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Improving Seniors’ Timely Access to Care Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
ENROLL Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
ENROLL Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
ENROLL Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Department of Defense Appropriations Act, 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R. 4016 - Department of Defense Appropriations Act, 2026 S. 2572 - Department of Defense Appropriations Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R.3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 H.R.7148 - Consolidated Appropriations Act, 2026 In January, joined with coalition partners to thank House leadership for including critical funding for programs that are essential to individuals with disabilities, chronic conditions, and injuries in the appropriations conference report. Supported the passage of H.R.7148, the Consolidated Appropriations Act, which included funding priorities for FY 26. Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program. Joined with coalition partners to send a letter to the Appropriations Committee leadership on NIH funding.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1 - One Big Beautiful Bill Act H.R. 4016 - Department of Defense Appropriations Act, 2026 S. 2572 - Department of Defense Appropriations Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R.3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 H.R.7148 - Consolidated Appropriations Act, 2026 In January, joined with coalition partners to thank House leadership for including critical funding for programs that are essential to individuals with disabilities, chronic conditions, and injuries in the appropriations conference report. Supported the passage of H.R.7148, the Consolidated Appropriations Act, which included funding priorities for FY 26. Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program. Joined with coalition partners to send a letter to the Appropriations Committee leadership on NIH funding.
Health Care Freedom for Patients Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Health Care Freedom for Patients Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Health Care Freedom for Patients Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
PBM FAIR Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
PBM FAIR Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
PBM FAIR Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
Air Carrier Access Amendments Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 9373: Air Carrier Access Amendments Act of 2026 S. 4829: Air Carrier Access Amendments Act In April joined with coalition partners a letter to the Department Of Transportation requesting updates on the status of DOTs implementation of the disability-related provisions of the FAA Reauthorization Act of 2024 and urging DOT to meet the requirements specified by Congress.
Accelerating Kids’ Access to Care Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Accelerating Kids’ Access to Care Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
Accelerating Kids’ Access to Care Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Lifespan Respite Care Reauthorization Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Lifespan Respite Care Reauthorization Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
Lifespan Respite Care Reauthorization Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Credit for Caring Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
Credit for Caring Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Credit for Caring Act of 2025
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Insurance Fraud Accountability Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
Insurance Fraud Accountability Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
Insurance Fraud Accountability Act
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Joined with coalition partners to request CMS to expand coverage for anti-obesity medications. In January commented on CMS's Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly. In April provided recommendations on CMS's Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
S. 925 - Credit for Caring Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2320 - The Mobility Means Freedom Tax Credit Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Commented and proposed recommendations on FDA's Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products as well as FDA's Artificial Intelligence-Enabled Device Software Functions.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Supporting the following funding levels in FY25 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2026. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to restore funding for the Congressionally Directed MS Research Program which was zeroed out in the last Continuing Resolution. Specifically $22 million for the MS Research Program and $6.54 Million for Veterans Affairs Centers of Excellence.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: NATIONAL MULTIPLE SCLEROSIS SOCIETY · Firm: NATIONAL MULTIPLE SCLEROSIS SOCIETY
H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
H.R.1 - One Big Beautiful Bill Act Continued to advocate on H.R.1 implementation. In July, the National MS Society commented on CMSs Medicaid Community Engagement Requirement centering around administrative barriers that could jeopardize health coverage for people living with MS and other chronic conditions, and urging CMS to maintain robust protections and exemptions to ensure uninterrupted access to care and treatment.
H.R.1 - One Big Beautiful Bill Act H.R.7779 - Healthy Brains Act of 2026 H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 In July, the National MS Society submitted comments on the Office of Management and Budgets (OMB) proposed Regulation for Federal Financial Assistance, expressing concern over impacts the rule may have on grant review and federal research investments.
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 National MS Society submitted comments to the Centers for Medicare and Medicaid Service's (CMS) request for information on essential health benefits (EHB) urging the agency to monitor the provision of EHB as well and to update and strengthen benefit standards The National MS Society responded to CMS request for information (RFI) around implementing certain pharmacy benefit manager (PBM) reforms passed by Congress in January 2026. The Society comments focused on the need to better understand the complexities of the drug supply chain system by collecting as much information as possible from the broadest number of stakeholders. Additionally, comments outlined the access concerns many people living with MS face as a result of the system as it currently stands. The National MS commented on the Calendar Year 2026 Hospital Outpatient Prospective Payment System (OPPS) Proposed Rule, to preserve patient access to affordable outpatient care and ensure adequate reimbursement policies that support access to infusion therapies, specialty services, and other critical treatments for people living with MS
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2026 · second_quarter · Q2
H.R.1 - One Big Beautiful Bill Act Continued to advocate on H.R.1 implementation. Submitted and joined coalition comments to CMS on the proposed rule on Interoperability Standards and Prior Authorization for Drugs. The aimed looked to modernize prior authorization processes and improve interoperability across the healthcare system. Joined with coalition partners to respond to a pair of proposed Local Coverage Determinations (LCDs) and the impacts how it would impact how power seat elevation systems are covered under Medicare. In May, Joined a coalition letter to Congress requesting outreach to CMS to encourage the agency to rescind the Low Vision Aid Exclusion under the Medicare regulations.
H.R.8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 H.R.9495 - Department of Defense Appropriations Act, 2027 Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. In April joined with coalition partners on a Congressional letter requesting $90.47 Million for the NIEHS Superfund Program, including the SRP and WTP.These programs are housed in NIH. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program. In May, joined with coalition partners to thank SAC and HAC LHHS committees for including provisions aimed at safeguarding public health investments. Additionally joined with coalition partners on a letter to Defense committee leadership to increase funding for the Congressionally Directed Medical Research Programs (CDMRP) at the Department of Defense (DoD).
H.R. 1 - One Big Beautiful Bill Act (implementation) H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 8270: Every Dollar Counts Act of 2026 S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Submitted comments to Department of Labor on its proposed rule: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure. Submitted comments to the Food and Drug Administration (FDA) on the Impacts of Patient-Focused Drug Development Meetings. The comments emphasized the meetings are of critical importance for capturing meaningful, disease-specific patient input at scale.
H.R.1 - One Big Beautiful Bill Act H.R.7779 - Healthy Brains Act of 2026 H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 Over the course of the last quarter joined with various coalition partners to advocate for NIH funding grants for medical research. Submitted comments to the National Institutes of Health on the agency's request for feedback on its Framework for the next NIH-Wide Strategic Plan.
H.R. 9373: Air Carrier Access Amendments Act of 2026 S. 4829: Air Carrier Access Amendments Act In April joined with coalition partners a letter to the Department Of Transportation requesting updates on the status of DOTs implementation of the disability-related provisions of the FAA Reauthorization Act of 2024 and urging DOT to meet the requirements specified by Congress.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Administration, SENATE, Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2026 · first_quarter · Q1
H.R.1 - One Big Beautiful Bill Act H.R.7148 - Consolidated Appropriations Act, 2026 Continued to advocate on H.R.1 implementation. Submitted and joined coalition comments to HHS on the proposed rule to revise the Medicare Advantage (MA), Medicare Prescription Drug Benefit (Part D), and Medicare cost plan regulations.
H.R. 1 - One Big Beautiful Bill Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 H.R.5081 - Telehealth Modernization Act H.R. 5940, the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient, Recovery (SMARTER) Care Act of 2025 H.R.6183 - To amend the Internal Revenue Code of 1986 to reform certain rules related to health savings accounts. H.R.6837 - To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 S. 3549 - PBM FAIR Act S. 3386 - Health Care Freedom for Patients Act of 2025 Joined a coalition comment letter in response to the HHS Notice of Benefit and Payment Parameters for 2027 proposed rule. These comments focused on key proposals related to enrollees in need of, the essential health benefit (EHB) category of rehabilitation and habilitation services and devices.
H.R.1 - One Big Beautiful Bill Act H.R. 4016 - Department of Defense Appropriations Act, 2026 S. 2572 - Department of Defense Appropriations Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R.3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 H.R.7148 - Consolidated Appropriations Act, 2026 In January, joined with coalition partners to thank House leadership for including critical funding for programs that are essential to individuals with disabilities, chronic conditions, and injuries in the appropriations conference report. Supported the passage of H.R.7148, the Consolidated Appropriations Act, which included funding priorities for FY 26. Advocated for funding levels in FY27 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2027. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to ensure $1.626 billion in funding for the Congressionally Directed MS Research Program in FY 27. Specifically advocating for $22 million for the MS Research Program. Joined with coalition partners to send a letter to the Appropriations Committee leadership on NIH funding.
H.R.1 - One Big Beautiful Bill Act H.R.7148 - Consolidated Appropriations Act, 2026 H.R.7779 - Healthy Brains Act of 2026 Over the course of the last quarter joined with various coalition partners to advocate for NIH funding grants for medical research. Submitted comments to U.S. Department of Health and Human Services (HHS) on the agency's request for feedback on how current HHS regulations affect the adoption and use of artificial intelligence (AI) in clinical care.
Joined with several disability groups to respond to DOT's request for comments on disability-related air travel complaints received by air carriers. The group urged the department to continue to require air carriers to report and categorize disability-related complaints received due to DOT legislative requirements and practical reasons. Joined with disability groups to comment on DOT's Notice Regarding Investigatory and Enforcement Policies and Procedures of the Office of Aviation Consumer Protection. The comment emphasized that OACP must continue to assess monetary penalties for violations of the ACAA.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2025 · fourth_quarter · Q4
H.R.1 - One Big Beautiful Bill Act H.R. 4016 - Department of Defense Appropriations Act, 2026 S. 2572 - Department of Defense Appropriations Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R.3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 Supporting the following funding levels in FY25 appropriations bills: $51.3 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2026. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to restore funding for the Congressionally Directed MS Research Program which was zeroed out. Specifically advocating for $22 million for the MS Research Program. Joined with coalition partners to send a letter to the Appropriations Committee leadership on the NIH-wide strategic plan asking for report language to ensure the plan is carefully executed with input from key stakeholders that prioritize cutting edge research and investments.
H.R. 1 - One Big Beautiful Bill Act S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 Worked with coalition partners to advocate for the renewal of Enhanced Premium Tax Credits (eAPTCs). Met with various Members of Congress to explain the importance of these credits for their constituents.
H.R.1 - One Big Beautiful Bill Act
H.R.1 - One Big Beautiful Bill Act Over the course of the last quarter joined with various coalition partners to advocate for restoring NIH funding grants for medical research. Worked with partners to ask Appropriations Committee leadership for report language on the NIH-wide strategic plan to ensure the plan is carefully executed with input from key stakeholders that prioritize cutting edge research and investments.
Joined with a broad coalition of charitable organizations urging OPM suspend any action to cancel the Combined Federal Campaign (CFC).
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, Office of Personnel Management (OPM), SENATE, Veterans Affairs, Dept of (VA)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2025 · third_quarter · Q3
H.R.1 - One Big Beautiful Bill Act H.R. 4016 - Department of Defense Appropriations Act, 2026 S. 2572 - Department of Defense Appropriations Act, 2026 H.R. 5304 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 H.R.3944 - Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026 Supporting the following funding levels in FY25 appropriations bills: $51.3 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2026. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to restore funding for the Congressionally Directed MS Research Program which was zeroed out. Specifically advocating for $22 million for the MS Research Program. Joined with coalition partners to send a letter to the Appropriations Committee leadership on the NIH-wide strategic plan asking for report language to ensure the plan is carefully executed with input from key stakeholders that prioritize cutting edge research and investments.
H.R. 1 - One Big Beautiful Bill Act S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025 H.R.4317 - PBM Reform Act of 2025 Worked with coalition partners to advocate for the renewal of Enhanced Premium Tax Credits (eAPTCs). Met with various Members of Congress to explain the importance of these credits for their constituents.
H.R.1 - One Big Beautiful Bill Act Joined with coalition partners to ask CMS to eliminate Medicare guidance that prohibits Medicare coverage of standing systems in power wheelchairs. Encouraged the agency to initiate rulemaking to create and establish a timelier and more predictable pathway for Medicare coverage of Food and Drug Administration (FDA) designated breakthrough medical technologies.
H.R.1 - One Big Beautiful Bill Act Over the course of the last quarter joined with various coalition partners to advocate for restoring NIH funding grants for medical research. Worked with partners to ask Appropriations Committee leadership for report language on the NIH-wide strategic plan to ensure the plan is carefully executed with input from key stakeholders that prioritize cutting edge research and investments. Worked with other groups to send a Letter to Appropriations Committee leadership supporting the work of the Joint Associations Group on Indirect Costs (JAG)s effort to develop a new, more transparent model for ensuring that institutions essential research costs are adequately supported.
Joined with a broad coalition of charitable organizations urging OPM suspend any action to cancel the Combined Federal Campaign (CFC).
Commented on DOL's proposed changes Section 503 of the Rehabilitation Act, specifically on changes that allowed the employees of Federal Contractors self-identify disability status and the elimination of disability utilization goal for Federal Contractors.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Administration, Office of Personnel Management (OPM), SENATE, Veterans Affairs, Dept of (VA)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2025 · second_quarter · Q2
H.R.1 - One Big Beautiful Bill Act Supporting the following funding levels in FY25 appropriations bills: $51.3 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2026. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to restore funding for the Congressionally Directed MS Research Program which was zeroed out in the last Continuing Resolution. Specifically $22 million for the MS Research Program.
H.R. 1 - One Big Beautiful Bill Act S. 752 - Accelerating Kids' Access to Care Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 S. 925 - Credit for Caring Act of 2025 S. 976 - Insurance Fraud Accountability Act H.R. 1509 - Accelerating Kids' Access to Care Act of 2025 S. 1816 - Improving Seniors' Timely Access to Care Act of 2025 S. 2024 - ENROLL Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2079 - Insurance Fraud Accountability Act H.R. 2320 - Mobility Means Freedom Tax Credit Act H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 3417 - Websites and Software Applications Accessibility Act of 2025 H.R. 3514 - Improving Seniors' Timely Access to Care Act of 2025 H.R. 3907 - ENROLL Act of 2025
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2025 · first_quarter · Q1
H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Supporting the following funding levels in FY25 appropriations bills: $51.303 billion for the National Institutes of Health (NIH) for fiscal year (FY) 2026. Supporting established funding levels for Medicare and Medicaid and protection of Medicaid's current financing structure. DoD- Working to restore funding for the Congressionally Directed MS Research Program which was zeroed out in the last Continuing Resolution. Specifically $22 million for the MS Research Program and $6.54 Million for Veterans Affairs Centers of Excellence.
S. 925 - Credit for Caring Act of 2025 H.R. 2036 - Credit for Caring Act of 2025 H.R. 2320 - The Mobility Means Freedom Tax Credit Act S. 830 - Lifespan Respite Care Reauthorization Act of 2025 H.R. 2560 - Lifespan Respite Care Reauthorization Act of 2025 H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Commented and proposed recommendations on FDA's Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products as well as FDA's Artificial Intelligence-Enabled Device Software Functions.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2024 · fourth_quarter · Q4
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 1692, Health Care Affordability Act of 2023 H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage H.R. 8018, the Alleviating Barriers for Caregivers Act, support passage S. 3109, the Alleviating Barriers for Caregivers Act, support passage H.R.6302, the Health Share Transparency Act of 2023 H.R.7623, the Telehealth Modernization Act of 2024
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2024 · third_quarter · Q3
Supporting the following funding levels in FY25 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.5 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51.3 billion for the National Institutes of Health, and at least $ 53.85 billion for the Indian Health Service. DoD- $20 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense - Dept of (DOD), Food & Drug Administration (FDA), Veterans Affairs - Dept of (VA), Natl Institutes of Health (NIH)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2024 · second_quarter · Q2
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage The Biosimilar Red Tape Elimination Act, monitor legislation U.S. HOUSE OF REPRESENTATIVES, U.S. Senate, Natl Institutes of Health (NIH), Defense - Dept of (DOD), Food & Drug Administration (FDA), Veterans Affairs - Dept of (VA)
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage H.R. 8018, the Alleviating Barriers for Caregivers Act, support passage S. 3109, the Alleviating Barriers for Caregivers Act, support passage H.R.6302, the Health Share Transparency Act of 2023 Joined together with coalition allies to offer recommendations for the 2026 Notice of Benefit and Payment Parameters (NBPP), as well as future rulemaking, to advance the goals of making healthcare accessible, adequate, and affordable. Joined together with coalition allies to advocate to the federal government, including HHS and CMS, to ensure that any revision of the cost-sharing rule related to copay accumulator adjustment policies includes clear, commonsense protections guaranteeing that copayments made by or on behalf of an enrollee are counted as payments toward their annual cost-sharing contributions.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2024 · first_quarter · 1A
Support legislation that would: maintaining current Medicaid funding structure and make the enhanced advance premium tax credits permanent, support limiting the use of inadequate short-term limited duration and other non-ACA compliant plans, address affordability of health insurance out-of-pocket costs by shifting the APTC benchmark from silver plans to gold plans to decrease out of pocket exposure for patients, ensuring the actuarial value of plans accurately reflect the financial risk faced by most consumers enrolled in the plan, support and expand Medicaid coverage in states that have not yet expanded. S.1967, Patients Before Middlemen Act, support passage S.2973, Modernizing and Ensuring PBM Accountability Act, support passage (awaiting bill number) S.2254, Medicare PBM Accountability Act, support passage
Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. H.R. 3746- the Fiscal Responsibility Act of 2023- monitor for impact on priority issues. Opposed discussed provision to require Medicaid work requirements.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2024 · first_quarter · Q1
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2023 · fourth_quarter · Q4
Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. H.R. 3746- the Fiscal Responsibility Act of 2023- monitor for impact on priority issues. Opposed discussed provision to require Medicaid work requirements.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2023 · third_quarter · Q3
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2023 · second_quarter · Q2
Support legislation that would: maintaining current Medicaid funding structure and make the enhanced advance premium tax credits permanent, support limiting the use of inadequate short-term limited duration and other non-ACA compliant plans, address affordability of health insurance out-of-pocket costs by shifting the APTC benchmark from silver plans to gold plans to decrease out of pocket exposure for patients, ensuring the actuarial value of plans accurately reflect the financial risk faced by most consumers enrolled in the plan, support and expand Medicaid coverage in states that have not yet expanded. S.1967, Patients Before Middlemen Act, support passage S.XXX, Modernizing and Ensuring PBM Accountability Act, support passage S.2254, Medicare PBM Accountability Act, support passage
Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. H.R. 3746- the Fiscal Responsibility Act of 2023- monitor for impact on priority issues. Opposed discussed provision to require Medicaid work requirements.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2023 · first_quarter · Q1
Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · third_quarter · 3A
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
FY2023 Defense Appropriations Act- support $22 million for the MS Research Program FY2023 LHHS Appropriations Act - at least $49 billion for the NIHs base and that any funding for the new ARPA-H, or for other targeted programs like pandemic preparedness, supplement the $49 billion recommendation for NIHs base budget, at least $5 million for the CDC National Neurological Conditions Surveillance System FY23-House/Senate Military Construction, VA and Related Agencies Appropriations bill - supporting double funding for the VA MS Centers of Excellence ($5 million) and the following report language - Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments into the headache and epilepsy centers and encourages their continued ongoing support and . The Committee directs the Department to make similar investments in the multiple sclerosis and Parkinsons disease centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 forParkinsons disease.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · fourth_quarter · 4A
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684 With respect to the aforementioned bills, we are monitoring the implementation aspects. Focus on broadband infrastructure to support investments in telehealth expansion after the PHE.
COVID-19 vaccine prioritization and distribution-supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendations and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · fourth_quarter · Q4
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684 With respect to the aforementioned bills, we are monitoring the implementation aspects. Focus on broadband infrastructure to support investments in telehealth expansion after the PHE.
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · third_quarter · 3A
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684 With respect to the aforementioned bills, we are monitoring the implementation aspects. Focus on broadband infrastructure to support investments in telehealth expansion after the PHE.
H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 5376, Inflation Reduction Act (support passage, particularly drug pricing provisions)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · third_quarter · 3A
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
FY2023 Defense Appropriations Act- support $22 million for the MS Research Program FY2023 LHHS Appropriations Act - at least $49 billion for the NIHs base and that any funding for the new ARPA-H, or for other targeted programs like pandemic preparedness, supplement the $49 billion recommendation for NIHs base budget, at least $5 million for the CDC National Neurological Conditions Surveillance System FY23-House/Senate Military Construction, VA and Related Agencies Appropriations bill - supporting double funding for the VA MS Centers of Excellence ($5 million) and the following report language - Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments into the headache and epilepsy centers and encourages their continued ongoing support and . The Committee directs the Department to make similar investments in the multiple sclerosis and Parkinsons disease centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 forParkinsons disease.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · third_quarter · Q3
H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 5376, Inflation Reduction Act (support passage, particularly drug pricing provisions)
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · second_quarter · Q2
H.R.3 - Elijah Cummings Lower Drug Costs Now, monitor legislation S.151- "COVID HCBS Relief Act of 2021"- support passage H.R. 4131- "To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes."- support passage H.R. 2455 - The Resetting the IMPACT Act (TRIA) of 2021." - support passage H.R. 1319- The American Rescue Plan Act of 2021, support passage H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation.
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2022 · first_quarter · Q1
Prescription Drug User Fee Act- supporting goals of the Prescription Drug User Fee commitment letter between the Food and Drug Administration and industry partners and legislation to reauthorize the prescription drug user fee program at FDA and resulting initiative. Supporting funding increase for the National Institutes of Health, the Centers for Disease Control and Prevention and the Food and Drug Administration in FY22 Appropriations bills and other research focus funding supplemental legislation. H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage Senator Kaine Accelerated Approval bill - support passage S. 3799 Prevent Pandemics Act - support passage
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2021 · fourth_quarter · Q4
Prescription Drug User Fee Act- supporting goals of the Prescription Drug User Fee commitment letter between the Food and Drug Administration and industry partners and legislation to reauthorize the prescription drug user fee program at FDA and resulting initiative. Supporting funding increase for the National Institutes of Health, the Centers for Disease Control and Prevention and the Food and Drug Administration in FY22 Appropriations bills and other research focus funding supplemental legislation. H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2021 · third_quarter · Q3
H.R. 1319 - American Rescue Plan Act of 2021 - support passage H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage
NATIONAL MULTIPLE SCLEROSIS SOCIETY via NATIONAL MULTIPLE SCLEROSIS SOCIETY
2021 · second_quarter · Q2
H.R. 1319 - American Rescue Plan Act of 2021 - support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage
H.R.1 - One Big Beautiful Bill Act Joined with coalition partners to request CMS to expand coverage for anti-obesity medications. In June Commented and proposed recommendations on CMS's Draft Guidance for the Medicare Drug Price Negotiation Program.
H.R.1 - One Big Beautiful Bill Act Over the course of the last quarter joined with various coalition partners to advocate for restoring NIH funding grants for medical research.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. Joined with coalition partners to request CMS to expand coverage for anti-obesity medications. In January commented on CMS's Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly. In April provided recommendations on CMS's Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability.
H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025 H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
Supporting the following funding levels in FY25 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.5 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51.3 billion for the National Institutes of Health, and at least $ 53.85 billion for the Indian Health Service. DoD- $20 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense - Dept of (DOD), Food & Drug Administration (FDA), Veterans Affairs - Dept of (VA), Natl Institutes of Health (NIH)
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage The Biosimilar Red Tape Elimination Act, monitor legislation U.S. HOUSE OF REPRESENTATIVES, U.S. Senate, Natl Institutes of Health (NIH), Defense - Dept of (DOD), Food & Drug Administration (FDA), Veterans Affairs - Dept of (VA)
S.1967, Patients Before Middlemen Act, support passage S.2973, Modernizing and Ensuring PBM Accountability Act, support passage S.2254, Medicare PBM Accountability Act, support passage Support legislation that would impact Medicare/Medicaid health care costs through Pharmacy Benefit Manager (PBM) reform.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
S.1967, Patients Before Middlemen Act, support passage S.2973, Modernizing and Ensuring PBM Accountability Act, support passage S.2254, Medicare PBM Accountability Act, support passage Support legislation that would impact Medicare/Medicaid health care costs through Pharmacy Benefit Manager (PBM) reform.
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage The Biosimilar Red Tape Elimination Act, monitor legislation U.S. HOUSE OF REPRESENTATIVES, U.S. Senate, Natl Institutes of Health (NIH), Defense - Dept of (DOD), Food & Drug Administration (FDA), Veterans Affairs - Dept of (VA)
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 1692, Health Care Affordability Act of 2023 H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage H.R. 8018, the Alleviating Barriers for Caregivers Act, support passage S. 3109, the Alleviating Barriers for Caregivers Act, support passage H.R.6302, the Health Share Transparency Act of 2023 H.R.7623, the Telehealth Modernization Act of 2024
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
Support legislation that would: maintaining current Medicaid funding structure and make the enhanced advance premium tax credits permanent, support limiting the use of inadequate short-term limited duration and other non-ACA compliant plans, address affordability of health insurance out-of-pocket costs by shifting the APTC benchmark from silver plans to gold plans to decrease out of pocket exposure for patients, ensuring the actuarial value of plans accurately reflect the financial risk faced by most consumers enrolled in the plan, support and expand Medicaid coverage in states that have not yet expanded. S.1967, Patients Before Middlemen Act, support passage S.2973, Modernizing and Ensuring PBM Accountability Act, support passage (awaiting bill number) S.2254, Medicare PBM Accountability Act, support passage In June, the Society provided input on prototype Medicare Prescription Payment Plan documents released by the Centers for Medicare and Medicaid Services. The Societys comments focused on suggestions to improve these documents so that all Medicare beneficiaries will be able to understand how to access this program regardless of preferred language or disability status. U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Office of Administration
Supporting the following funding levels in FY25 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.5 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51.3 billion for the National Institutes of Health, and at least $ 53.85 billion for the Indian Health Service. DoD- $20 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense - Dept of (DOD), Food & Drug Administration (FDA), Veterans Affairs - Dept of (VA), Natl Institutes of Health (NIH)
Supported the Federal Aviation Administration (FAA) Reauthorization bill, HR 3935, the Securing Growth and Robust Leadership in American Aviation Act. This reauthorization bill contained several disability-related accessibility provisions the Society advocated for to improve safety and accessibility, including: new training requirements for assisting passengers with limited mobility and properly stowing assistive devices to prevent damage. Submitted individual and signed onto coalition comments on the Federal Aviation Administration (FAA)s proposed rule on Ensuring Safe Accommodations for Air Travelers with Disabilities Using Wheelchairs. The proposed rule contains numerous provisions which look to remove barriers to air travel for people who have disabilities and asking for feedback on safe and dignified air travel.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.1939 FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. H.R. 3746- the Fiscal Responsibility Act of 2023- monitor for impact on priority issues. Opposed discussed provision to require Medicaid work requirements.
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.1939 FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
Support legislation that would: maintaining current Medicaid funding structure and make the enhanced advance premium tax credits permanent, support limiting the use of inadequate short-term limited duration and other non-ACA compliant plans, address affordability of health insurance out-of-pocket costs by shifting the APTC benchmark from silver plans to gold plans to decrease out of pocket exposure for patients, ensuring the actuarial value of plans accurately reflect the financial risk faced by most consumers enrolled in the plan, support and expand Medicaid coverage in states that have not yet expanded. S.1967, Patients Before Middlemen Act, support passage S.2973, Modernizing and Ensuring PBM Accountability Act, support passage (awaiting bill number) S.2254, Medicare PBM Accountability Act, support passage
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.1939 FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
Support legislation that would: maintaining current Medicaid funding structure and make the enhanced advance premium tax credits permanent, support limiting the use of inadequate short-term limited duration and other non-ACA compliant plans, address affordability of health insurance out-of-pocket costs by shifting the APTC benchmark from silver plans to gold plans to decrease out of pocket exposure for patients, ensuring the actuarial value of plans accurately reflect the financial risk faced by most consumers enrolled in the plan, support and expand Medicaid coverage in states that have not yet expanded. S.1967, Patients Before Middlemen Act, support passage S.2973, Modernizing and Ensuring PBM Accountability Act, support passage (awaiting bill number) S.2254, Medicare PBM Accountability Act, support passage
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation Committee Draft -The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage S.79- Interagency Patent Coordination and Improvement Act of 2023, support passage S. 142- Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148- Stop STALLING Act, support passage S.150- Affordable Prescriptions for Patients Act of 2023, support passage S.775-Increasing Transparency in Generic Drug Applications Act, monitoring S.1067-Ensuring Timely Access to Generics Act of 2023, support passage S. 2780 Medication Affordability and Patent Integrity Ac H.R. 4189, the CONNECT for Health Act, support passage H.R. 1843, the Telehealth Expansion Act, support passage Alleviating Barriers for Caregiving Act, support passage (not yet introduced) Health Share Transparency Act, support passage (not yet introduced)
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.1939 FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Prevention (inclusive of $5 million for the National Neurological Conditions Surveillance System), $20 million for the Lifespan Respite Care Program, Robust support for Medicare and Medicaid and protection of Medicaid's current financing structure, $51 billion for the National Institutes of Health, any funding for the Advanced Research Projects Agency for Health should supplement, rather than supplant NIH core investment and at least $15.5 billion for the Social Security Administration. FDA - $372 million increase in BA (taxpayer) funding, including $3 million to fund the Neurology Drug Program. MilConVA- support inclusion of report language that includes Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for recent investments into headache, multiple sclerosis, and Parkinsons disease centers and acknowledges the advancement and expansion the Centers have begun. The Committee encourages further investment and collaboration of the Centers across disciplines and directs the Department to allocate at least $72,500,000 for the Neurology Centers of Excellence for maintenance and expansion. Within this total, the Committee recommends the following amounts: $19,000,000 for epilepsy; $30,000,000 for headache; $7,500,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. DoD- $22 million for the MS Research Program and increased baseline funding of at least 5% plus inflation for the Congressionally Directed Medical Research Programs. H.R. 3746- the Fiscal Responsibility Act of 2023- monitor for impact on priority issues. Opposed discussed provision to require Medicaid work requirements.
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R.1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage H.R. 2940/ S.135, the PASTEUR Act of 2023, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
Support legislation that would: maintaining current Medicaid funding structure and make the enhanced advance premium tax credits permanent, support limiting the use of inadequate short-term limited duration and other non-ACA compliant plans, address affordability of health insurance out-of-pocket costs by shifting the APTC benchmark from silver plans to gold plans to decrease out of pocket exposure for patients, ensuring the actuarial value of plans accurately reflect the financial risk faced by most consumers enrolled in the plan, support and expand Medicaid coverage in states that have not yet expanded. S.1967, Patients Before Middlemen Act, support passage S.2973, Modernizing and Ensuring PBM Accountability Act, support passage (awaiting bill number) S.2254, Medicare PBM Accountability Act, support passage
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
H.R. 3935, Securing Growth and Robust Leadership in American Aviation Act of 2023, support passage S.XX FAA Reauthorization Act of 2023, support passage with Amendments that includes components of ACAAA (listed below) S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R. 1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage H.R. 2940/ S.135, the PASTEUR Act of 2023, support passage The Biosimilar Red Tape Elimination Act, monitor legislation
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community. S. 2333 - Pandemic and All-Hazards Preparedness and Response Act, support passage H.R. 824, Telehealth Benefit Expansion for Workers Act of 2023, oppose passage H.R. 4421, Preparing for All Hazards and Pathogens Reauthorization Act, monitor legislation H.R. 4420, Preparedness and Response Reauthorization Act, monitor legislation SXX,The Primary Care and Health Workforce Expansion Act, support passage S. 1339, the Pharmacy Benefit Manager Reform Act, support passage S.127, the PBM Transparency Act of 2023, support passage S.113, The Prescription Pricing for the People Act of 2023, support passage S.2052, Protect Patient Access to Pharmacies Act H.R. 3561, the PATIENT Act of 2023, support passage H.R. 3284, Providers and Payers Compete Act, support passage H.R. 4507, Transparency in Coverage Act, support passage H.R. 4508, Hidden Fee Disclosure Act, support passage H.R. 2816, PBM Sunshine and Accountability Act, support passage
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
S.652 - Safe Step Act (Murkowski/Hassan), support passage H.R. 830 - HELP Copays Act, support passage S.935- Fair Accountability and Innovative Research Drug Pricing Act of 2023, support passage H.R. 485, Protecting Health Care For All Patients Act, oppose passage as currently written S.127, the Pharmacy Benefit Manager Transparency Act, support passage Urged HELP and House Energy and Commerce Committee to hold roundtables and advance proposals that address workforce issues within the healthcare community.
S.79 - Interagency Patent Coordination and Improvement Act of 2023, support passage S.113, the Prescription Pricing for the People Act of 2023,support passage S.142, the Preserve Access to Affordable Generics and Biosimilars Act, support passage S.148, the Stop Stalling Act, support passage S.150, the Affordable Prescriptions for Patients Act of 2023, support passage H.R. 1114- Long COVID Recovery Now Act S.801/H.S. 1616 CARE for Long COVID Act, support passage
2023 Reauthorization of the Federal Aviation Administration, support passage S.545/H.R.1267 - Air Carrier Access Amendments Act of 2023, support passage H.R. 14445/S.400 - Prioritizing Accountability and Accessibility for Aviation Consumers Act of 2023, support passage
Support legislation that would: maintaining current Medicaid funding structure and make the enhanced advance premium tax credits permanent, support limiting the use of inadequate short-term limited duration and other non-ACA compliant plans, address affordability of health insurance out-of-pocket costs by shifting the APTC benchmark from silver plans to gold plans to decrease out of pocket exposure for patients, ensuring the actuarial value of plans accurately reflect the financial risk faced by most consumers enrolled in the plan, support and expand Medicaid coverage in states that have not yet expanded.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684 With respect to the aforementioned bills, we are monitoring the implementation aspects. Focus on broadband infrastructure to support investments in telehealth expansion after the PHE.
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 5376, Inflation Reduction Act (support passage, particularly drug pricing provisions)
H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress Commitment to America-GOP Public Policy plan- monitoring developments H.R.5376 Inflation Reduction Act- Support passage.
COVID-19 vaccine prioritization and distribution-supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendations and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
H.R. 2617, Consolidated Appropriations Act FY 2023 Omnibus Package-support final passage. FY2023 LHHS Appropriations Act: At least $49 billion for the NIHs base and any funding for the new ARPA-H, or for other targeted programs, including pandemic protection. A least $5 million for the CFC National Neurological Conditions Surveillance System. FY2023 House/Senate Military Construction, VA, and Related Agencies: Support double funding for the VA MS Centers of Excellence ($5 million) and the following report language: The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments in the multiple sclerosis and Parkinsons dases centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. FY2023 Defense Appropriations Act - support $22 million for MS Research Program: Support $22 million for the MS Research Program
H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress
H.R. 2617, Consolidated Appropriations Act FY 2023 Omnibus Package-support final passage. FY2023 LHHS Appropriations Act: At least $49 billion for the NIHs base and any funding for the new ARPA-H, or for other targeted programs, including pandemic protection. A least $5 million for the CFC National Neurological Conditions Surveillance System. FY2023 House/Senate Military Construction, VA, and Related Agencies: Support double funding for the VA MS Centers of Excellence ($5 million) and the following report language: The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinsons disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments in the multiple sclerosis and Parkinsons dases centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 for Parkinsons disease. FY2023 Defense Appropriations Act - support $22 million for MS Research Program: Support $22 million for the MS Research Program
H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
COVID-19 vaccine prioritization and distribution-supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendations and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
COVID-19 vaccine prioritization and distribution-supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendations and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress Commitment to America-GOP Public Policy plan- monitoring developments H.R.5376 Inflation Reduction Act- Support passage.
FY2023 Defense Appropriations Act- support $22 million for the MS Research Program FY2023 LHHS Appropriations Act - at least $49 billion for the NIHs base and that any funding for the new ARPA-H, or for other targeted programs like pandemic preparedness, supplement the $49 billion recommendation for NIHs base budget, at least $5 million for the CDC National Neurological Conditions Surveillance System FY23-House/Senate Military Construction, VA and Related Agencies Appropriations bill - supporting double funding for the VA MS Centers of Excellence ($5 million) and the following report language - Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments into the headache and epilepsy centers and encourages their continued ongoing support and . The Committee directs the Department to make similar investments in the multiple sclerosis and Parkinsons disease centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 forParkinsons disease.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress Commitment to America-GOP Public Policy plan- monitoring developments H.R.5376 Inflation Reduction Act- Support passage.
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684 With respect to the aforementioned bills, we are monitoring the implementation aspects. Focus on broadband infrastructure to support investments in telehealth expansion after the PHE.
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 5376, Inflation Reduction Act (support passage, particularly drug pricing provisions)
COVID-19 vaccine prioritization and distribution-supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendations and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
FY2023 Defense Appropriations Act- support $22 million for the MS Research Program FY2023 LHHS Appropriations Act - at least $49 billion for the NIHs base and that any funding for the new ARPA-H, or for other targeted programs like pandemic preparedness, supplement the $49 billion recommendation for NIHs base budget, at least $5 million for the CDC National Neurological Conditions Surveillance System FY23-House/Senate Military Construction, VA and Related Agencies Appropriations bill - supporting double funding for the VA MS Centers of Excellence ($5 million) and the following report language - Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments into the headache and epilepsy centers and encourages their continued ongoing support and . The Committee directs the Department to make similar investments in the multiple sclerosis and Parkinsons disease centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 forParkinsons disease.
COVID-19 vaccine prioritization and distribution-supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendations and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684 With respect to the aforementioned bills, we are monitoring the implementation aspects. Focus on broadband infrastructure to support investments in telehealth expansion after the PHE.
H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress Commitment to America-GOP Public Policy plan- monitoring developments H.R.5376 Inflation Reduction Act- Support passage.
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Administration, SENATE, Veterans Affairs, Dept of (VA)
H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)
H.R. 1319 - American Rescue Plan Act - support passage COVID-19 vaccine prioritization and distribution - supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendation and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684
H.R. 1319 - American Rescue Plan Act of 2021 - support passage H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage Healthy Futures Task Force- monitoring subcommittee recommendations and plans for health priorities in the 118th Congress
H.R.1319- The American Rescue Plan Act of 2021 - support passage FY 22 House/Senate Defense Appropriations Act -Supporting -$20 million for the MS Research Program FY 22 House/Senate Labor, Health and Human Services and Education Act-$500 million for the Agency for Healthcare Research and Quality (AHRQ),$10 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $14.2 million for the Lifespan Respite Care Program; Robust support for Medicare and Medicaid and protection of Medicaids current financing structure; and at least $46.1 billion for the National Institute of Health (NIH), full funding for the Patient Centered Outcomes Research Institute (PCORI); and at least $13.5 billion for the Social Security Administrations administrative budget. FY 22 House/Senate - Military Construction, Veterans Affairs, and Related Agencies Appropriations bill - sustainable, predictable funding for the VA Multiple Sclerosis Centers of Excellence. Additionally, we urge this Committee to include report language that expresses its support for all the Neurology Centers of Excellence in the FY22 appropriations report language. Our suggested language is below: Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Department is directed to significantly increase its investment to maintain and expand existing centers of excellence within the VA dedicated to these conditions to enhance their value in coordinating innovative clinical care, education, and research efforts. No later than 120 days after enactment of this Act the Committee directs the Secretary to submit a report to the Committees providing details on opportunities to enhance care for veterans with neurologic conditions, including potential collaboration between the neurology centers of excellence. H. Res. 101/S.Con.Res.5 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030, support passage FY2023 Defense Appropriations Act- support $22 million for the MS Research Program FY2023 LHHS Appropriations Act - at least $49 billion for the NIHs base and that any funding for the new ARPA-H, or for other targeted programs like pandemic preparedness, supplement the $49 billion recommendation for NIHs base budget, at least $5 million for the CDC National Neurological Conditions Surveillance System FY23-House/Senate Military Construction, VA and Related Agencies Appropriations bill - supporting double funding for the VA MS Centers of Excellence ($5 million) and the following report language - Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to: epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Neurology Centers of Excellence provide essential innovative clinical care, education, and research efforts focused on these conditions. The Committee applauds the Department for its recent investments into the headache and epilepsy centers and encourages their continued ongoing support and . The Committee directs the Department to make similar investments in the multiple sclerosis and Parkinsons disease centers, which have not received a significant increase in funding for nearly 20 years. This bill includes at least the following amounts for maintaining and expanding the Neurology Centers of Excellence: $19,000,000 for epilepsy. $25,000,000 for headache; $5,000,000 for multiple sclerosis; and $16,000,000 forParkinsons disease.
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
H.R.3 - Elijah Cummings Lower Drug Costs Now, monitor legislation S.151- "COVID HCBS Relief Act of 2021"- support passage H.R. 4131- "To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes."- support passage H.R. 2455 - The Resetting the IMPACT Act (TRIA) of 2021." - support passage H.R. 1319- The American Rescue Plan Act of 2021, support passage H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act, support passage
H.R.1319- The American Rescue Plan Act of 2021 - support passage FY 22 House/Senate Defense Appropriations Act -Supporting -$20 million for the MS Research Program FY 22 House/Senate Labor, Health and Human Services and Education Act-$500 million for the Agency for Healthcare Research and Quality (AHRQ),$10 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $14.2 million for the Lifespan Respite Care Program; Robust support for Medicare and Medicaid and protection of Medicaids current financing structure; and at least $46.1 billion for the National Institute of Health (NIH), full funding for the Patient Centered Outcomes Research Institute (PCORI); and at least $13.5 billion for the Social Security Administrations administrative budget. FY 22 House/Senate - Military Construction, Veterans Affairs, and Related Agencies Appropriations bill - sustainable, predictable funding for the VA Multiple Sclerosis Centers of Excellence. Additionally, we urge this Committee to include report language that expresses its support for all the Neurology Centers of Excellence in the FY22 appropriations report language. Our suggested language is below: Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Department is directed to significantly increase its investment to maintain and expand existing centers of excellence within the VA dedicated to these conditions to enhance their value in coordinating innovative clinical care, education, and research efforts. No later than 120 days after enactment of this Act the Committee directs the Secretary to submit a report to the Committees providing details on opportunities to enhance care for veterans with neurologic conditions, including potential collaboration between the neurology centers of excellence. H. Res. 101/S.Con.Res.5 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030, support passage FY2023 Defense Appropriations Act- support $22 million for the MS Research Program" FY2023 LHHS Appropriations Act - at least $49 billion for the NIHs base and that any funding for the new ARPA-H, or for other targeted programs like pandemic preparedness, supplement the $49 billion recommendation for NIHs base budget, at least $5 million for the CDC National Neurological Conditions Surveillance System
H.R. 1319 - American Rescue Plan Act - support passage COVID-19 vaccine prioritization and distribution - supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendation and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R. 1319 - American Rescue Plan Act of 2021 - support passage H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
H.R.3 - Elijah Cummings Lower Drug Costs Now, monitor legislation S.151- "COVID HCBS Relief Act of 2021"- support passage H.R. 4131- "To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes."- support passage H.R. 2455 - The Resetting the IMPACT Act (TRIA) of 2021." - support passage H.R. 1319- The American Rescue Plan Act of 2021, support passage H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684
H.R. 804, the FAMILY Act to entitle employees to a family and medical leave insurance monthly benefit for 2 months of qualified caregiving- support passage. Supporting proposals to include Paid Family and Medical Leave policies and provisions within the H.R. 5376, the Build Back Better Act
H.R. 1319 - American Rescue Plan Act of 2021 - support passage H.R. 5376, Build Back Better Act, support passage S. 898- Fair Accountability and Innovative Research Drug Pricing Act of 2021 - support passage S. 368/H.R. 1332 - Telehealth Modernization Act - support passage S.464/H.R. 2163- Safe Step Act, support passage H.R. 366 - Protecting Access to Post-COVID-19 Telehealth Act of 2021 - support passage H.R. 4418 - SPIKE Act- "To amend title XI of the Social Security Act to provide for drug manufacturer price transparency."- support passage S.2210-."Better Care Better Jobs Act"- support passage S.2164- "Lower Costs, More Cures Act of 2021"- support passage S.1524/H.R. 3029- "Health Care PRICE Transparency Act"- support passage S.1428/H.R. 2891-"Preserve Access to Affordable Generics and Biosimilars Act"- support passage S.1427/H.R. 2869-"Increasing Access to Biosimilars Act of 2021"- support passage H.R.2846-"Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021"-support passage H.R.2843-"STOP GAMES Act of 2021"- support passage H.R.3-"Elijah E. Cummings Lower Drug Costs Now Act" - support passage H.R.2855-"Star Rating for Biosimilars Act"- support passage S.164-"Advancing Education on Biosimilars Act of 2021"- support passage H.R.19- "Lower Costs, More Cures Act of 2021"- support passage Wyden Releases Principles For Lowering Drug Prices for Americans, support passage H.R. 2503, Social Determinants Accelerator Act of 2021, support passage S.1524/H.R.3029- Health Care Price Transparency Act, support passage H.R. 2884- Affordable Prescriptions for Patients Through Improvement t o Patent Litigation Act, support passage H.R. 2873- Affordable Prescriptions for Patients Through Promoting Competition Act of 2021, support passage H.R. 5365, Primary Health Services Enhancement Act, support passage H.R. 2575, Social Security Disability Insurance Return to Work Act, monitor for position determination S.2565- Expanding Access to Palliative Care Act, monitor for impact on people affected by MS H.R. 4714- Disabled Access Credit Expansion Act of 2021- support passage S. 1435, Affordable Prescriptions for Patients Act of 2021, monitor for position determination H.R. 3971, Double Dip Elimination Act, monitor for position determination H.R. 3765, Disability Employment Incentive Act, support passage H.R. 5801, Help Copays Act, support passage
H.R.1319- The American Rescue Plan Act of 2021 - support passage FY 22 House/Senate Defense Appropriations Act -Supporting -$20 million for the MS Research Program FY 22 House/Senate Labor, Health and Human Services and Education Act-$500 million for the Agency for Healthcare Research and Quality (AHRQ),$10 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $14.2 million for the Lifespan Respite Care Program; Robust support for Medicare and Medicaid and protection of Medicaids current financing structure; and at least $46.1 billion for the National Institute of Health (NIH), full funding for the Patient Centered Outcomes Research Institute (PCORI); and at least $13.5 billion for the Social Security Administrations administrative budget. FY 22 House/Senate - Military Construction, Veterans Affairs, and Related Agencies Appropriations bill - sustainable, predictable funding for the VA Multiple Sclerosis Centers of Excellence. Additionally, we urge this Committee to include report language that expresses its support for all the Neurology Centers of Excellence in the FY22 appropriations report language. Our suggested language is below: Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Department is directed to significantly increase its investment to maintain and expand existing centers of excellence within the VA dedicated to these conditions to enhance their value in coordinating innovative clinical care, education, and research efforts. No later than 120 days after enactment of this Act the Committee directs the Secretary to submit a report to the Committees providing details on opportunities to enhance care for veterans with neurologic conditions, including potential collaboration between the neurology centers of excellence. H. Res. 101/S.Con.Res.5 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030, support passage
S.243- Legacy IRA Act - support passage H.R.1219/S.331- ABLE Age Adjustment Act- increases age threshold for tax-favored ABLE accounts- support passage S.1670/H.R.3321- Credit for Caring Act, support passage S.2481 - Disabled Access Credit Expansion Act of 2021, support passage
H.R. 1319 - American Rescue Plan Act - support passage COVID-19 vaccine prioritization and distribution - supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendation and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
H.R.3 - Elijah Cummings Lower Drug Costs Now, monitor legislation S.151- "COVID HCBS Relief Act of 2021"- support passage H.R. 4131- "To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes."- support passage H.R. 2455 - The Resetting the IMPACT Act (TRIA) of 2021." - support passage H.R. 1319- The American Rescue Plan Act of 2021, support passage H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage
H.R. 1319 - American Rescue Plan Act - support passage COVID-19 vaccine prioritization and distribution - supported policies ensuring people with conditions that placed them at a higher risk of severe covid-19 were able to be prioritized in CDC-ACIP recommendation and for vaccine distribution plans. Supporting updates and changes Supplemental Security Income (SSI) program to increase the benefit to at least the federal poverty level, increase and index resource limits, eliminate marriage penalties, eliminate outdated rules about in-kind support from friends and family, and update outdated income disregards.
H.R.1319- The American Rescue Plan Act of 2021 - support passage FY 22 House/Senate Defense Appropriations Act -Supporting -$20 million for the MS Research Program FY 22 House/Senate Labor, Health and Human Services and Education Act-$500 million for the Agency for Healthcare Research and Quality (AHRQ),$10 billion for the Centers for Disease Control and Prevention (CDC) inclusive of $5 million for the National Neurological Conditions Surveillance Program authorized in the 21st Century Cures Act; $14.2 million for the Lifespan Respite Care Program; Robust support for Medicare and Medicaid and protection of Medicaids current financing structure; and at least $46.1 billion for the National Institute of Health (NIH), full funding for the Patient Centered Outcomes Research Institute (PCORI); and at least $13.5 billion for the Social Security Administrations administrative budget. FY 22 House/Senate - Military Construction, Veterans Affairs, and Related Agencies Appropriations bill - sustainable, predictable funding for the VA Multiple Sclerosis Centers of Excellence. Additionally, we urge this Committee to include report language that expresses its support for all the Neurology Centers of Excellence in the FY22 appropriations report language. Our suggested language is below: Neurology Centers of Excellence. - The Committee recognizes the increasing number of Veterans affected by neurologic conditions, including but not limited to epilepsy, headache, multiple sclerosis, and Parkinson's disease. The Department is directed to significantly increase its investment to maintain and expand existing centers of excellence within the VA dedicated to these conditions to enhance their value in coordinating innovative clinical care, education, and research efforts. No later than 120 days after enactment of this Act the Committee directs the Secretary to submit a report to the Committees providing details on opportunities to enhance care for veterans with neurologic conditions, including potential collaboration between the neurology centers of excellence. H. Res. 101/S.Con.Res.5 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030, support passage
S.243- Legacy IRA Act - support passage H.R.1219/S.331- ABLE Age Adjustment Act- increases age threshold for tax-favored ABLE accounts- support passage S.1670/H.R.3321- Credit for Caring Act, support passage S.2481 - Disabled Access Credit Expansion Act of 2021, support passage
H.R. 3684 - Infrastructure Investment and Jobs Act/Investing in a New Vision for the Environment and Surface Transportation in America Act or the INVEST in America Act, support passage S.1680/H.R. 3317 - All Stations Accessibility Act of 2021 (ASAP Act), support passage and inclusion in Bipartisan Infrastructure Act/H.R. 3684
Supporting Paid Family and Medical Leave policies and provisions within the Budget reconciliation and infrastructure packages
Prescription Drug User Fee Act- supporting goals of the Prescription Drug User Fee commitment letter between the Food and Drug Administration and industry partners and legislation to reauthorize the prescription drug user fee program at FDA and resulting initiative. Cures 2.0 discussion draft- supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal. Supporting funding increase for the National Institutes of Health, the Centers for Disease Control and Prevention and the Food and Drug Administration in FY22 Appropriations bills and other research focus funding supplemental legislation. H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
Prescription Drug User Fee Act- supporting goals of the Prescription Drug User Fee commitment letter between the Food and Drug Administration and industry partners and legislation to reauthorize the prescription drug user fee program at FDA and resulting initiative. Cures 2.0 discussion draft- supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal. Supporting funding increase for the National Institutes of Health, the Centers for Disease Control and Prevention and the Food and Drug Administration in FY22 Appropriations bills and other research focus funding supplemental legislation.
H.R.3 - Elijah Cummings Lower Drug Costs Now, monitor legislation S.151- "COVID HCBS Relief Act of 2021"- support passage H.R. 4131- "To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes."- support passage
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE